We are focused on first-in-class treatments for rare, genetic, and inflammatory disorders with multiple potential therapies for orphan, breakthrough and pediatric designations.

The Phoenicis culture is based on a sense purpose balanced with sustainable and profitable solutions to attract future talent and sustain our efforts and successes. Our mission and deeply experienced team guide us on our path as we work to make life more normal for those affected by rare disorders. Phoenicis has the vision, team, and product breadth and depth to pursue success and significant shareholder value creation.

 

Phoenicis leverages the power of innovative collaborations to develop therapies that bring hope and relief to people living with rare disorders. Our track record of value creation, mission-driven mindset, deep peer support empowers our joint vision of providing relief to people while creating a market leading company.

Phoenicis leverages the power of innovative collaborations to develop therapies that bring hope and relief to people living with rare disorders.

The Phoenicis team has a mission-driven mindset and long track record of value creation. Our senior management has worked together in multiple companies to create value for more than 10 years.

Our R&D team has created 15+ businesses, advanced 12+ drugs into the clinic, and been involved with 4 FDA and 3 EMA drug approvals in the last decade.

Our Leadership

Phoenicis’ senior management team has worked together in multiple companies to create value for stakeholders for over a decade.

Our founders have deep experience in business creation, drug development and approvals; along with deep relationships with regulators and a unique patient community perspective.

This gives Phoenicis a key competitive advantage for value creation and deep KOL support in our vision of creating a leader in rare disorder therapies.

Deborah Ramsdell

CEO / COO
Board Member

x

Hal Landy, MD

Chief Medical Officer

x

Board of Directors

Alex Silver

Board Chairman

x

Mark de Souza, PhD

Board Member

x

Joff Masukawa

Board Member

x

Scientific Advisory Board

Barbara Gilchrest, MD

Chairperson,
Scientific Advisory Board

x

Martin M. Okun, PhD

Scientific Advisory Board

x

Contact us for
more information